A detailed history of Qtron Investments LLC transactions in Amgen Inc stock. As of the latest transaction made, Qtron Investments LLC holds 5,536 shares of AMGN stock, worth $1.76 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
5,536
Previous 5,536 -0.0%
Holding current value
$1.76 Million
Previous $1.57 Million 9.92%
% of portfolio
0.25%
Previous 0.23%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$268.87 - $324.56 $481,546 - $581,286
-1,791 Reduced 24.44%
5,536 $1.57 Million
Q3 2023

Nov 13, 2023

BUY
$218.65 - $271.46 $206,842 - $256,801
946 Added 14.83%
7,327 $1.97 Million
Q2 2023

Aug 10, 2023

SELL
$214.27 - $253.37 $28,069 - $33,191
-131 Reduced 2.01%
6,381 $1.42 Million
Q4 2022

Feb 13, 2023

BUY
$229.03 - $291.01 $115,431 - $146,669
504 Added 8.39%
6,512 $1.71 Million
Q2 2022

Aug 10, 2022

BUY
$230.71 - $256.74 $417,585 - $464,699
1,810 Added 43.12%
6,008 $1.46 Million
Q4 2021

Feb 16, 2022

BUY
$198.88 - $227.6 $293,149 - $335,482
1,474 Added 54.11%
4,198 $944,000
Q2 2021

Aug 11, 2021

SELL
$233.58 - $259.14 $76,847 - $85,257
-329 Reduced 10.78%
2,724 $664,000
Q1 2021

May 13, 2021

SELL
$221.91 - $258.6 $164,657 - $191,881
-742 Reduced 19.55%
3,053 $760,000
Q4 2020

Feb 12, 2021

BUY
$216.38 - $257.67 $123,985 - $147,644
573 Added 17.78%
3,795 $873,000
Q2 2020

Aug 13, 2020

SELL
$197.81 - $242.74 $295,528 - $362,653
-1,494 Reduced 31.68%
3,222 $760,000
Q1 2020

May 14, 2020

BUY
$182.24 - $241.7 $182,240 - $241,700
1,000 Added 26.91%
4,716 $956,000
Q2 2019

Aug 13, 2019

BUY
$166.7 - $195.41 $80,016 - $93,796
480 Added 14.83%
3,716 $685,000
Q1 2019

May 13, 2019

SELL
$180.87 - $203.88 $1,627 - $1,834
-9 Reduced 0.28%
3,236 $615,000
Q4 2018

Feb 14, 2019

BUY
$178.4 - $208.25 $578,908 - $675,771
3,245 New
3,245 $632,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $170B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Qtron Investments LLC Portfolio

Follow Qtron Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qtron Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Qtron Investments LLC with notifications on news.